Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs-Reference-Cited by-同舟云学术

Long-range PCR libraries and next-generation sequencing for pharmacogenetic studies of patients treated with anti-TNF drugs

Published:2018-10-08 Issue:4 Volume:19 Page:358-367
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Walczak Michal,Skrzypczak-Zielinska Marzena,Plucinska Marianna,Zakerska-Banaszak Oliwia,Marszalek Daria,Lykowska-Szuber Liliana,Stawczyk-Eder Kamila,Dobrowolska Agnieszka,Slomski Ryszard

Funder

Foundation for the Development of Biotechnology and Genetics POLBIOGEN. Kamila Stawczyk-Eder is recipient of a fellowship for young researcher from Poznan Medical University (Poland).

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/s41397-018-0058-9.pdf

Reference30 articles.

1. Atzeni F, Talotta R, Salaffi F, Cassinotti A, Varisco V, Battellino M, et al. Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev. 2013;12:703–8.

2. Roberts RL, Barclay ML. Current relevance of pharmacogenetics in immunomodulation treatment for Crohn’s disease. J Gastroenterol Hepatol. 2012;27:1546–54.

3. Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn’s disease: results from a single-centre cohort. Gut. 2009;58:492–500.

4. Altwegg R, Vincent T. TNF blocking therapies and immunomonitoring in patients with inflammatory bowel disease. Mediat Inflamm. 2014;2014:e172821. https://doi.org/10.1155/2014/172821

5. Siegel CA, Melmed GY. Predicting response to anti-TNF agents for the treatment of Crohn’s disease. Ther Adv Gastroenterol. 2009;2:245–51.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROCZNICA ODKRYCIA STRUKTURY DNA – NOWE WYZWANIA DLA MEDYCYNY;Fides, Ratio et Patria. Studia Toruńskie;2023-12-29

2. Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn’s disease patients;Journal of Applied Genetics;2023-09-02

3. Variants of the CASP9 gene as candidate markers for primary response to anti-TNF therapy in Crohn's disease patients;2023-08-16

4. Beyond assembly: the increasing flexibility of single-molecule sequencing technology;Nature Reviews Genetics;2023-05-09

5. Lentiviral Transduction-based CRISPR/Cas9 Editing of Schistosoma mansoni Acetylcholinesterase;Current Genomics;2023-05